For the Inventor, By the Inventor

Enter assignee name

Watertown, MA, United States of America

Psivida US, Inc.

USPTO Granted Patents = 18

% Expired Patents = 38.9

CIPO Patents = 4

EPO Patents = 2

Trademarks = 4

Forward Citations = 282

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Paul Ashton (15 out of 31 patents)

Hong Guo (11 out of 17 patents)

Leigh Trevor Canham (7 out of 42 patents)

4. Jianbing Chen (5 out of 9 patents)

5. Christian Barnett (4 out of 5 patents)

6. Martin Nazzaro (3 out of 7 patents)

7. Josh York (3 out of 5 patents)

8. Ron Leblanc (3 out of 5 patents)

9. Dongling Su (2 out of 19 patents)

10. David A Watson (1 out of 13 patents)

11. Robert W Shimizu (1 out of 5 patents)

12. Kang-Jye Chou (1 out of 1 patent)

18 patents: Sort by Forward Citations

1. 9980911 - Bioerodible silicon-based compositions for delivery of therapeutic agents (2018-05-29),

2. 9962396 - Porous silicon drug-eluting particles (2018-05-08),

3. 9849085 - Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof (2017-12-26),

4. 9808421 - Bioerodible silicon-based devices for delivery of therapeutic agents (2017-11-07),

5. 9603801 - Bioerodible silicon-based compositions for delivery of therapeutic agents (2017-03-28),

6. 9566336 - In situ gelling drug delivery system (2017-02-14),

7. 9486459 - Porous silicon drug-eluting particles (2016-11-08),

8. 9333173 - Bioerodible silicon-based devices for delivery of therapeutic agents (2016-05-10),

9. 9192579 - Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof (2015-11-24),

10. 9023896 - Porous silicon drug-eluting particles (2015-05-05),

11. 8871241 - Injectable sustained release delivery devices (2014-10-28),

12. 8815284 - Bioerodible sustained release drug delivery systems (2014-08-26),

13. 8790293 - Injector apparatus with fixed plunger and method of use (2014-07-29),

14. 8574659 - Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof (2013-11-05),

15. 8574613 - Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof (2013-11-05),

pSivida US, Inc. is a specialty pharmaceutical company focused on the development of innovative drug delivery products to treat chronic eye diseases. Their proprietary Medidur technology uses tiny, sustained-release intravitreal implants to provide long-term drug delivery to the eye. This technology has been used in the treatment of various eye conditions such as diabetic macular edema and posterior uveitis. By providing sustained drug release, pSivida aims to improve treatment outcomes and reduce the burden of frequent injections for patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

18 Patents

#24 in Watertown, MA

#1,097 in Massachusetts

#17,933 in US

#34,146 in the World

Watertown, MA, United States of America

Psivida US, Inc.

Forward Citations = 282

12 inventors:

Paul Ashton (15 out of 31 patents)

Hong Guo (11 out of 17 patents)

Leigh Trevor Canham (7 out of 42 patents)

4. Jianbing Chen (5 out of 9 patents)

5. Christian Barnett (4 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…